NCT05215093

Brief Summary

Previous research showed that direct access to physiotherapy, and the associated early physiotherapeutic treatment of patients with low back pain (LBP), results in improved clinical outcomes, as well as reduced health-related costs. However, despite these results, the effectiveness of direct access to physiotherapy and its impact on costs has never been investigated in Belgium. Therefore, the goal of this study is to compare the (cost-)effectiveness of direct access to physiotherapy compared to usual care by the general practitioner (GP) for patients with acute LBP. In this study, 600 patients with acute LBP (lasting \>24 hours and \<6 weeks) will be divided into two groups (Dutch-speaking: n=2x150; French-speaking n= 2x150). One group will receive treatment through direct access to the physiotherapist, without prescription by a GP. The other group will follow the traditional care pathway through the GP. Th effects on pain, disability and cost-effectiveness will be analysed using questionnaires obtained before and at the end of treatment, after 3 months, after one and after two years. Primary outcomes include pain and disability. Secondary outcomes include clinical outcomes, beliefs related to LBP, quality of life, patient satisfaction, but also direct health care costs, health care resource use, as well as absenteeism and productivity loss. The results of this study will answer the question whether direct access to physiotherapy is (cost)effective for acute LBP. In the long term, these results might be used to optimize the care pathway in Belgium for patients with acute low back pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 31, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

2 years

First QC Date

December 13, 2021

Last Update Submit

February 27, 2023

Conditions

Keywords

Direct access

Outcome Measures

Primary Outcomes (3)

  • Changes in pain intensity

    Numeric Rating Scale

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  • Changes in pain location and extent

    Pain Diagram of Margolis

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  • Changes in disability

    Oswestry Disability Index

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

Secondary Outcomes (5)

  • Cost-effectiveness of the provided treatment (direct physiotherapy access vs usual care for acute low back pain)

    Up to 2 years after enrollment

  • Changes in beliefs and cognitions related to low back

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  • Changes in patient satisfaction

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  • Changes in quality of life

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  • Amount of / coping with flare-ups during follow-up

    Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

Study Arms (2)

Direct physiotherapy pathway

EXPERIMENTAL

People with acute low back pain will directly go to a physiotherapist, who will treat the patient without prescription of the general practitioner.

Other: Direct access physiotherapy for acute low back pain

Usual care pathway

ACTIVE COMPARATOR

People with low back pain will receive usual care by the general practitioner (with or without referral to physiotherapy).

Other: Usual care for acute low back pain

Interventions

Interventions include physiotherapeutic treatment, without prescription of the general practitioner, for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.

Direct physiotherapy pathway

Interventions include standard of care by the general practitioner for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.

Usual care pathway

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with non-specific acute LBP defined as (based on Nicol et al. 2020):
  • pain between the 12th rib and buttocks
  • associated or not with non-dominant leg pain
  • looking for LBP care for the first time in case of first episode, OR for the first time for the current episode in case of recurrent or persistent LBP
  • lasting \> 24 hours and \< 6 weeks
  • with an average pain intensity during the past 24 hours of ≥ 3 on an 11-point Numerical Pain Rating Scale
  • with an Oswestry Disability Index score (version 2.1a) of at least 20% (Denteneer et al. 2018).
  • Patients aged between 18 and 65 years

You may not qualify if:

  • Recent lumbar surgery (\< 1 year)
  • Pregnancy
  • History of (any) treatment for the current pain episode
  • Generalized musculoskeletal pain (based on fibromyalgia criteria) (Galvez-Sánchez and Reyes del Paso 2020).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

REVAL Faculty of Rehabilitation Sciences

Diepenbeek, 3590, Belgium

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lotte Janssens, PhD

    UHasselt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pieter Severijns, PhD

CONTACT

Lotte Janssens, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 13, 2021

First Posted

January 31, 2022

Study Start

December 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

February 28, 2023

Record last verified: 2023-02

Locations